SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurochem (NRMX)
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
54 10 0 NRMX
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
54I cashed in my bear spreads a few days ago. Had I held on, I would have made 25tuck-7/17/2007
53Wow, big option volume today, particularly in the August puts where my spread istuck-6/25/2007
52Hah! Now they are saying results sometime this <b>year</b>! They&#tuck-6/22/2007
51NRMX: RBC Cap Downgrades Price Target 75% ... from C$7.50 to C$2 a share ... biMLD38-6/13/2007
50NRMX ($5.75) -- Next wave should be UP! <img src=&#pcyhuang-6/11/2007
49No long awaited results, alas. They are now hinting that it might take longer ttuck-6/11/2007
48Delisted from the Canadian S&P TSX Index, and long awaited results monday. enigma7-6/9/2007
47NMRX @$5.75 -- A Short Squeeze Imminent? On Nasdaq Failed-to-deliver List fopcyhuang-6/9/2007
46Saw this morning that one of the Analysts that writes research on Neurochem is senigma7-6/7/2007
45NRMX -- Reaching reaction target? <img src='http://stockcharts.com/c-sc/pcyhuang-6/7/2007
44>>Neurochem announces it has obtained written consent from its shareholdertuck-6/5/2007
43NRMX : from C/W's Shulman BioTechBlitz Blog His most recent blog entry is, MLD38-5/18/2007
42From today's 1Q07 PR: The European Phase III clinical trial on tramiprosatekenhott-5/8/2007
41I am looking for some further research and opinions about Allon Therapeutics, anenigma7-5/3/2007
40Activity in Neurochem Signals Hope for Stock By MOHAMMED HADI April 12, 2007; [Doc Bones-4/12/2007
39Neurochem's Risky Bet By Adam Feuerstein Senior Writer 1/22/2007 8:02 AM EDoc Bones-1/22/2007
38<b>Neurochem initiated with a sell</b> <i>NEW YORK, January 5Angelo Ferraro-1/5/2007
37from zacks, jason napodano, cfa; 1/4/07; current price: 19.90; 6 month target: software salesperson-1/4/2007
36A recent article that may be of interest: businessweek.com JackJack@SI-1/4/2007
35What's nuts is Dr. Bellini is also the ceo of nrmx.rkrw-1/4/2007
34Does this look like the Black Bear/Telik situation or what? And Greenberg -- whtuck-1/4/2007
33Picchio Pharma purchase of Neurochem shares Friday September 8, 10:57 am ET MOmopgcw-9/21/2006
32What is going on with this Company? Firstly, let me declare clearly that I do noutrun-8/19/2006
31Neurochem reports results for second quarter of fiscal 2006 - Announces Equity Lmopgcw-8/15/2006
30Neurochem receives approvable letter for eprodisate (Kiacta(TM)) for treatment omopgcw-8/15/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News